Market Cap : 161.36 B | Enterprise Value : 191.14 B | PE Ratio : 25.11 | PB Ratio : 4.95 |
---|
NYSE:BMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NYSE:BMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net margin is calculated as Net Income divided by its Revenue. Bristol-Myers Squibb Co's Net Income for the three months ended in Jun. 2022 was $1,421 Mil. Bristol-Myers Squibb Co's Revenue for the three months ended in Jun. 2022 was $11,887 Mil. Therefore, Bristol-Myers Squibb Co's net margin for the quarter that ended in Jun. 2022 was 11.95%.
The historical rank and industry rank for Bristol-Myers Squibb Co's Net Margin % or its related term are showing as below:
The historical data trend for Bristol-Myers Squibb Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's Net Margin % falls into.
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Bristol-Myers Squibb Co's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as
Net Margin | = | Net Income (A: Dec. 2021 ) | / | Revenue (A: Dec. 2021 ) |
= | 6994 | / | 46385 | |
= | 15.08 % |
Bristol-Myers Squibb Co's Net Margin for the quarter that ended in Jun. 2022 is calculated as
Net Margin | = | Net Income (Q: Jun. 2022 ) | / | Revenue (Q: Jun. 2022 ) |
= | 1421 | / | 11887 | |
= | 11.95 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Greenlees Sharon | officer: SVP & Controller | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Shanahan Karin | officer: EVP, Glob. Prod. Dev. & Supply | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Meyers Gregory Scott | officer: EVP, Chief Digital & Tech Off. | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Weese Michelle | officer: EVP, Corporate Affairs | BRISTOL MYERS SQUIBB ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Hidalgo Medina Manuel | director | BRISTOL MYERS SQUIBB 430 E. 29TH STREET, 14TH FLOOR NEW YORK NY 10016 |
Rice Derica W | director | 1000 NICOLLET MALL TPS-3155 MINNEAPOLIS MN 55403 |
Price Paula A | director | ONE CVS DRIVE WOONSOCKET RI 02895 |
Mily Elizabeth | officer: EVP, Strategy & BD | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVENCE LINE ROAD PRINCETON NJ 08540 |
Metcalfe Kathryn | officer: EVP, Corporate Affairs | BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 & PROVINCE LINE ROAD PRINCETON NJ 08543 |
Vessey Rupert | officer: Pres., Research & Early Dev. | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Elkins David V | officer: EVP, Chief Financial Officer | C/O BECTON, DICKINSON AND COMPANY 1 BECTON DRIVE FRANKLIN LAKES NJ 07417 |
Bonney Michael W | director | 65 HAYDEN AVE LEXINGTON MA 02421 |
Yale Phyllis R | director | |
Ahmed Nadim | officer: President, Hematology | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
Haller Julia A | director | C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 |
From GuruFocus
Other Sources
By Zacks 2022-04-05
By Zacks 2022-03-15
By Zacks 2022-03-29
By Zacks 2022-03-16
By Zacks 2022-03-21
By Zacks 2022-03-25
By Fool 2022-04-05
By Zacks 2022-03-31
By Zacks 2022-03-21
By Zacks 2022-04-05
By Zacks 2022-03-16
By tipranks.com 2022-03-21
By Zacks 2022-03-16
By Zacks 2022-04-04